Randomized, placebo-controlled, double-blind study assessing the efficacy and safety of paliperidone palmitate in Asian patients with schizophrenia

Overview of attention for article published in Neuropsychiatric Disease and Treatment, December 2013

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 25 publications that cite this research output.

25

The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.

Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review

Article in Neuropsychiatric Disease and Treatment (September 2023)

Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis

Article in Translational Psychiatry (December 2022)

Response efficacy and heterogeneity of antipsychotic drugs in schizophrenia: Systemic review and meta‐analysis

Article in Human Psychopharmacology Clinical and Experimental (August 2021)